Skye Bioscience, Inc. Increase (Decrease) in Income Taxes Payable
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Income Taxes Payable of $588 for the 29-month period ending 2013-07-31, per its 10-Q filed 2013-09-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2013-09-16
- Skye Bioscience, Inc. increase (decrease) in income taxes payable for the quarter ending 2013-07-31 was -$796.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 25 month | Increase (Decrease) in Income Taxes Payable 29 month |
|---|---|---|---|---|---|
| 2013-07-31 | -$796.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-16 | $342.00 10-Q · filed 2013-09-16 | $588.00 10-Q · filed 2013-09-16 | ||
| 2013-04-30 | $1.14K 10-Q · filed 2013-06-27 | $1.38K 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |